Resources
Select from the drop-down menu below to read the most up-to-date news about pelareorep.
May 26, 2019 | Publication
Fountzilas et al, ASCO Abstract, 2019
March 28, 2019 | Publication
Davola & Mossman, OncoImmunology, 2019
March 1, 2019 | Poster
Wilkinson Et al, AACR, 2019
January 14, 2019 | Publication
Thirukkumaram et al, Blood Advances, 2019
December 1, 2018 | Poster
Hofmeister et al, ASH, 2018
November 14, 2018 | Publication
LaRocca and Warner, Clinical and Translational Medicine, 2018
November 1, 2018 | Poster
Reovirus infection of prostate cancer induces upregulation of the negative regulators PD-L1 and BTLA
Pandha et al, SITC, 2018
October 1, 2018 | Poster
Goel et al, ESMO, 2018
Page 9 of 14
Expanded Access
Oncolytics believes that participating in clinical trials is the best way for patients to access pelareorep. We are not currently able to fulfill expanded access requests at this time.
Information on many of Oncolytics clinical trials can be found at ClinicalTrials.gov. If a treating doctor would like additional information, the doctor should formally contact Oncolytics at info@oncolyticsbiotech.com.
Contact Us
For questions regarding our science, partnership opportunities, or other inquiries, we encourage you to reach out.